What the Mounjaro weight loss journey actually looks like

Step 1: Clinical assessment and getting your first prescription

The journey begins before you ever open a pen. A prescriber reviews your medical history, current weight, BMI, and any related conditions to decide whether Mounjaro is appropriate for you. That is not a formality, it is a clinical decision, and it matters. The UK licence covers adults with a BMI of 30 or above, or 27 and above if you have at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Lower thresholds apply for some ethnic backgrounds under UK guidance.

At nume, a named GPhC-registered Independent Prescriber reads your consultation the same day it arrives. There is no algorithm making that call. Once approved, your treatment is dispatched the same working day if you order before 12pm, arriving the next working day by tracked DPD in plain packaging. If you have questions about how the consultation works, the FAQs page covers the most common ones.

Transfer patients and those requesting a dose increase are asked for evidence of their current treatment, that is standard clinical practice, and a sign of a pharmacy doing things properly. The prescription element is not a hurdle; it is the part that keeps the process safe.

Step 2: The first few weeks, adjustment, not results

Most people's Mounjaro journey in the UK starts at 2.5mg. The first pen's job is to help your system adjust, not to deliver dramatic weight loss. Some people notice reduced appetite almost immediately; others take a few weeks. Gastrointestinal side effects (nausea, loose stools, some bloating) are common early on and usually ease within the first two weeks as your body adapts. They tend to be more noticeable in the days after each injection.

Protein intake and staying well hydrated both matter here. Appetite often falls sharply, and some people undereat in the early weeks without realising. Keeping a simple record of what you eat can help, something our clinical team often suggests. One question our prescribers hear most weeks is whether it is normal to feel quite different after the first dose: yes, generally, and that feeling tends to settle.

You can read more about what the medication is doing at a biological level on the Mounjaro overview page, and about managing the early weeks in the Mounjaro journal resource. The NHS's tirzepatide guidance also has a clear summary of expected side effects and what to watch for.

Step 3: Titration and finding your dose

Every four weeks or so, your prescriber reviews whether it is time to increase your dose. The steps run from 2.5mg up through 5, 7.5, 10, 12.5 and 15mg, but not everyone needs to reach the top. The aim is the highest dose you tolerate well, not necessarily the highest dose available. Some people achieve meaningful weight loss at a mid-range dose and stay there.

This is where the weight loss results side of the journey becomes clearer. Weight tends to come off gradually and then, for many people, more steadily as the dose increases. Comparing week-by-week numbers is rarely useful; monthly trends tell a more accurate story. Keeping notes about energy, appetite and how clothes fit often reflects progress that the scales miss.

People sometimes ask about nutritional support during this phase. Vitamins and micronutrient needs can shift when appetite is suppressed for months, something worth raising with your prescriber. At this stage, concerns about how your weight is changing can be explored on the Mounjaro and weight changes page.

For a broader picture of how this fits into your overall options, the weight loss treatments overview page sets out what is available for UK adults in 2024.

Step 4: Long-term on Mounjaro, sustaining the results

The evidence from SURMOUNT-1 covers 72 weeks, but many people's real-world journey is longer. Weight loss typically slows after the first six months, that plateau is a normal physiological response, not a sign the medicine has stopped working. Staying at your maintenance dose, keeping active, and maintaining the dietary changes you built in earlier are what carry results forward.

Questions about dependency sometimes surface at this point. Tirzepatide does not cause physical dependence in the way that some substances can, the Is Mounjaro addictive? page addresses this properly. What does happen when people stop is that appetite regulation tends to return to its pre-treatment state, which is why ongoing clinical review matters.

At nume, every repeat order is clinically re-reviewed before it is dispensed. There are no subscriptions, no auto-renewals. If you want a frank conversation about pricing across the market, the Mounjaro price comparison page sets out the context honestly. The weight loss injection page is also worth reading if you are still weighing up the injection format.

Ready to see whether Mounjaro is clinically suitable for you? Start your free consultation with our prescribing team today.